SB 1688: Pharmaceutical Products Containing Cannabis

Summary

Excluding cannabis from Schedule I listing if it is contained within a pharmaceutical product approved by the United States Food and Drug Administration, etc.

Bill details

Sponsor

Joe Gruters

Current status

Died in Committee

Introduced

January 11, 2022

Status history

1. Died in Committee — January 11, 2022
   Migrated from existing bill record
   Source